Lanxess tops Q3 estimates, but narrows annual earnings view

By Reuters News

By Ozan Ergenay

- Speciality chemicals maker Lanxess LXSG.DE reported quarterly sales and earnings slightly above expectations on Thursday, helped by price hikes, but narrowed its annual earnings forecast as its core markets showed no broader recovery.

Its shares were up about 4% in early Frankfurt trade.

The Cologne-based company's third-quarter revenue rose 9.6% to €1.46 billion ($1.64 billion), compared to the €1.44 billion estimated in a company-provided poll.

It said the increase was driven mainly by price hikes to pass on higher raw material and energy costs.

Lanxess said it now expects its full-year earnings before interest, taxes, depreciation and amortisation (EBITDA) pre-exceptionals at the upper end of €450 million to €500 million range, compared with its previous forecast of €450 million to €550 million.

The company's quarterly EBITDA pre-exceptionals rose by 11.2% to €139 million, compared with an estimate of €138.2 million.

It said its free cash flow reached €48 million from a negative €14 million a year earlier, adding that it also expected a positive figure in the fourth quarter.

However, CEO Matthias Zachert said demand remained subdued across several of the company's core markets, particularly agrochemicals, automotive and construction, adding that ongoing cost-cutting measures were helping to support earnings.

The German chemicals sector, the country's third-largest, has been struggling with weak demand, high energy costs, supply chain disruptions and a broader economic slowdown.

Lanxess also warned that economic uncertainty remained elevated, citing the Middle East and Ukraine wars.

The Middle East conflict has disrupted fuel and feedstock markets, driving up prices for the energy‑intensive chemical industry and prompting companies to raise their prices.



($1 = 0.8880 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.